Skip to main content

With 6.0% CAGR, US Speech Therapy Market Size Hit USD 6.52 Billion in 2029

According to Fortune Business Insights, The US speech therapy market size was valued at USD 4.13 billion in 2021. The market is projected to grow from USD 4.35 billion in 2022 to USD 6.52 billion by 2029, exhibiting a CAGR of 6.0% during the forecast period.

Pune, India, Dec. 12, 2022 (GLOBE NEWSWIRE) — The US speech therapy market size was valued at USD 4.13 billion in 2021. The market is projected to grow from USD 4.35 billion in 2022 to USD 6.52 billion by 2029, exhibiting a CAGR of 6.0% during the forecast period.

This information is provided by Fortune Business Insights, in its report, titled, “U.S. Speech Therapy Market, 2022-2029.”

Get Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/sample/u-s-speech-therapy-market-105574



US Speech Therapy Market Report Scope & Segmentation :

Report Coverage Details
Forecast Period 2022 to 2029
Forecast Period 2022 to 2029 CAGR 6.0%
2029 Value Projection USD 6.52 Billion
Base Year 2021
Market Size in 2021 USD 4.13 Billion
Historical Data for 2018 to 2020
No. of Pages 63


COVID-19 Impacts:

Decline in Patient Visits Hindered Market Growth during COVID-19

The coronavirus outbreak little affected the marketplace. Due to the government-imposed lockdown limitations, a decrease in the number of referrals to Speech-language Pathologists (SLP) was seen in the nation during the pandemic. The adoption rate of speech language treatment among Americans was also constrained by a lack of infrastructure for virtual speech therapy.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/u-s-speech-therapy-market-105574


Segments:

Rising Prevalence of Key Speech Disorders Led to Segmental Dominance

Based on type, the market is segmented into speech disorders, language disorders, neurological conditions, swallowing disorders, and others. The speech disorders segment held a dominant U.S. speech therapy market share in 2021.

Pediatrics Segment to Dominate Market during the Forecast Period

Based on age, the market is categorized into pediatrics and adults. Among them, the pediatrics segment held a dominating share in 2021. The dominance is due to the increasing incidence of speech-language and swallowing disorders among children and the surging initiatives by the government to provide care across all schools and education facilities in the U.S.

Report Coverage:

The report offers a detailed study of the market and a keen examination of the major segments of the market. It provides an in-depth analysis of key players and their insightful strategies to spur the U.S. speech therapy market growth for monetary gains. It also shares tangible insights which guide business owners with their investment perspective. The regional dynamics and how they shape the market in an upward curve are presented in the following report. Moreover, COVID-19 impacts have been added for additional information and how it is expected to affect the demand for speech therapy in the near future.

Quick Buy – US Speech Therapy Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/105574


Drivers and Restraints:

Rising Prevalence of Speech & Language Disorders in the U.S. to Fuel Market Growth

There is a huge demand for effective treatment therapies since the U.S. population is becoming more and more affected by speech and language problems such as articulation, aphasia, stuttering, and others. Furthermore, according to numerous studies, a greater proportion of people with neurological illnesses such as Parkinson’s and stroke suffer from speech and vocal abnormalities, which, if left untreated, can have a negative impact on a patient’s quality of life.

The need for this therapy in the U.S. is expected to be primarily driven by the rising prevalence of speech disorders, their rising early diagnosis rate, and the demand for effective treatment. The cost-benefit ratio of the therapy, however, cannot be supported.

Competitive Landscape:

Important Business-related Decisions by Key Players to Influence Market Dynamics

Fundamental companies in the market often make crucial announcements regarding some business moves, which, in turn, affect the market either positively or negatively. Players acquire companies, launch new products, engage in partnership deals, sign contracts with government organizations, and so on.

Key Industry Development:

May 2022: In the Birmingham area, BenchMark Physical Therapy Institute launched an outpatient facility in Indian Springs Village to offer physical therapy services such as manual therapy, injury prevention, speech therapy, and others.

List of Key Players Mentioned in the Report:

  • Kindred Healthcare, LLC (U.S.)
  • Genesis Rehab Services (U.S.)
  • BenchMark Physical Therapy Institute (U.S.)
  • Reliant Rehabilitation (U.S.)
  • Humanus Corporation (U.S.)
  • Smart Speech Therapy (U.S.)
  • Therapy Solutions Inc. (U.S.)
  • Rehabilitation Associates, Inc. (U.S.)

Speak To Our Analyst: 

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-speech-therapy-market-105574


Table Of Contents :

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Overview of Regulatory & Reimbursement Scenario, U.S.
    • Recent Key Developments, Mergers, and Acquisitions, Key Players
    • Prevalence of Key Indications Leading to Speech Difficulty, U.S., 2021
    • Impact of COVID-19 on the Market
  • U.S. Speech Therapy Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Type
      • Speech Disorders
      • Language Disorders
      • Neurological Conditions
      • Swallowing Disorders
      • Others
    • Market Analysis, Insights and Forecast – By Age
      • Paediatrics
      • Adults
  • Competitive Analysis
    • U.S. Market Share Analysis (2021)
    • Company Profiles (Overview, Services, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      • Kindred Healthcare, LLC (U.S.)
      • Genesis Rehab Services (U.S.)
      • BenchMark Physical Therapy Institute (U.S.)
      • Reliant Rehabilitation (U.S.)
      • Humanus Corporation (U.S.)
      • Smart Speech Therapy (U.S.)
      • Therapy Solutions Inc. (U.S.)
      • Rehabilitation Associates, Inc. (U.S.)

Toc Continue…


Ask for Customization of this Report:

https://www.fortunebusinessinsights.com/enquiry/customization/u-s-speech-therapy-market-105574


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.